Free Trial

Global Cord Blood (NYSE:CO) Earns Strong-Buy Rating from Analysts at StockNews.com

Global Cord Blood logo with Medical background

StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO - Get Free Report) in a research note issued on Thursday. The brokerage set a "strong-buy" rating on the medical research company's stock.

Global Cord Blood Price Performance

NYSE CO opened at $1.05 on Thursday. Global Cord Blood has a 52 week low of $2.03 and a 52 week high of $5.50. The business's fifty day simple moving average is $0.92 and its 200-day simple moving average is $1.11. The firm has a market cap of $127.63 million, a PE ratio of 1.64 and a beta of 0.16.

Global Cord Blood Company Profile

(Get Free Report)

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Global Cord Blood Right Now?

Before you consider Global Cord Blood, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Cord Blood wasn't on the list.

While Global Cord Blood currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines